We have developed a database of research summaries that include leukodystrophy articles, clinical trials and pharmaceutical press releases to allow our community to easily read about relevant recent research developments.

Please use the drop down boxes below to narrow your search. You can search for condition specific summaries or to view our monthly research summaries which are sent out via email to our community, please select ‘Monthly summary’.

Search research summaries

27th May 2026

Research Summary: May 2026

Research summary of recent leukodystrophy research and clinical trials, includes article summaries and direct links to websites and articles. To access the summary: Research Summary – May 2026 Please be aware these summaries are produced voluntarily by Biomedical Science students and are their interpretations of the information and findings. This information is reviewed by our […]

30th April 2026

Transplantation of encapsulated mitochondria alleviates dysfunction in mitochondrial and Parkinson’s disease models

Leigh syndrome https://www.cell.com/cell/fulltext/S0092-8674(26)00230-8?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867426002308%3Fshowall%3Dtrue This study presents a novel mitochondrial transplantation approach using mitochondria encapsulated in vesicles derived from red blood cell membranes. Mitochondria are specialised organelles found in all human cells that create energy for your body and cells to function, while vesicles are small cellular structures that can do many things such as transport, […]

30th April 2026

Elevated Creatine Kinase in Mucolipidosis Type IV: Investigating an Atypical Manifestation and Its Clinical Complications

Mucolipidosis Type IV https://www.cureus.com/articles/446995-elevated-creatine-kinase-in-mucolipidosis-type-iv-investigating-an-atypical-manifestation-and-its-clinical-complications?score_article=true#! Mucolipidosis type IV (MLIV) is a very rare inherited disorder that affects how cells break down and recycle materials. It is caused by harmful changes in the MCOLN1 gene, which disrupts lysosomal function. Children with MLIV typically show early developmental delay, weak muscle tone, severe vision problems, and gastrointestinal difficulties. This […]

30th April 2026

Expanding the Clinicoradiologic Phenotype of the CTSA-Associated Small Vessel Disease CARASAL

Cathepsin-A Related Arteriopathy with Strokes And Leukoencephalopathy (CARASAL) https://www.neurology.org/doi/10.1212/NXG.0000000000200358 CARASAL is an extremely rare inherited disease that affects the brain’s small blood vessels. It is caused by a single change in the CTSA gene and can resemble the more common condition CADASIL, making diagnosis difficult. This study examined 21 people with CARASAL from three Dutch families and […]

30th April 2026

Clinical and imaging characteristics of NOTCH3-negative CADASIL-suspected patients with NOTCH2NLC GGC repeat expansions

Cerebral Autosomal Dominant Arteriopathy with Subcortical infarcts and Leukoencephalopathy (CADASIL) https://www.nature.com/articles/s10038-026-01470-1 Neuronal Intranuclear Inclusion Disease (NIID) is a neurodegenerative disorder caused by GGC repeat expansions in the NOTCH2NLC gene, often presenting with heterogeneous neurological symptoms and white matter changes on MRI. As these features overlap with other leukoencephalopathies, including CADASIL, some NIID cases may be misdiagnosed, particularly when standard […]

30th April 2026

Impairment of hippocampal gamma oscillations, mitochondria and neurovascular function in CADASIL

Cerebral Autosomal Dominant Arteriopathy with Subcortical infarcts and Leukoencephalopathy (CADASIL) https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awag033/8453165 This study examines how CADASIL, a genetic small vessel disease caused by mutations in the NOTCH3 gene, leads to brain dysfunction beyond its primary vascular pathology. While CADASIL is known to impair blood flow in the brain and cause strokes and vascular dementia, the downstream effects on neurons, […]

30th April 2026

X-linked adrenoleukodystrophy as an etiological cause of progressive spastic paraplegia: A case report

Adrenoleukodystrophy (ALD) https://pmc.ncbi.nlm.nih.gov/articles/PMC13009845 X‑linked adrenoleukodystrophy (X‑ALD) is a rare genetic disorder caused by mutations in the ABCD1 gene, which leads to the buildup of very long‑chain fatty acids in the body. The adult-onset form adrenomyeloneuropathy (AMN) is a slowly progressive condition that causes stiffness, weakness, and walking difficulties. Because brain and spinal MRI scans are […]

30th April 2026

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Krabbe Disease and GM2 Gangliosidosis https://investors.polaryx.com/pr/polaryx-therapeutics-receives-us-fda-fast-track-designations-for-all-four-indications-to-be-evaluated-in-the-soteria-basket-trial Polaryx Therapeutics has been granted Fast Track Designation (FTD) for PLX-200 for the treatment of Krabbe disease, GM2 Gangliosidosis and Juvenile Neuronal Ceroid Lipofuscinosis (JNCL/CLN3 disease). This treatment is being studied in their SOTERIA Phase 2 basket trial. The Fast Track program is a regulatory program that expedites the development and review of drugs intended to treat serious conditions and address unmet medical needs. This will help speed up and make […]

29th April 2026

Research Summary: April 2026

Research summary of recent leukodystrophy research and clinical trials, includes article summaries and direct links to websites and articles. To access the summary: Research Summary – April 2026 Please be aware these summaries are produced voluntarily by Biomedical Science students and are their interpretations of the information and findings. This information is reviewed by our […]

31st March 2026

Integrated stress response inhibition prolongs the lifespan of a Pelizaeus-Merzbacher disease mouse model by increasing oligodendrocyte survival

Pelizaeus-Merzbacher disease https://www.nature.com/articles/s41467-025-68045-0 Pelizaeus-Merzbacher disease (PMD) is a rare genetic disorder that damages the brain’s white matter. Children with PMD struggle with movement, muscle control, and development because their brains cannot make healthy myelin, the protective coating that helps nerve signals travel quickly. The disease is caused by mutations in the PLP1 gene, which lead […]

31st March 2026

System biology and network-based approach to identify the therapeutic signatures and potential inhibitors against polycystic lipomembranous osteodysplasia with Sclerosing Leukoencephalopathy

Nasu–Hakola disease also known as Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0343274 Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also called Nasu–Hakola disease, is a very rare genetic disorder that affects both the brain and the bones. People with this condition often develop bone cysts, memory loss, personality changes, and eventually severe dementia. Because […]